Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in AJR Am J Roentgenol Retrieve available abstracts of 47 articles: HTML format

Single Articles

September 2025
1. NGUYEN DL, Grimm LJ, Wells VA, Shpanskaya K, et al
   Echogenic Rind Associated With Suspicious Masses on Ultrasound: Performance for Breast Cancer Diagnosis and Associations With Pathologic Tumor Characteristics.
   AJR Am J Roentgenol. 2025 Sep 17. doi: 10.2214/AJR.25.33732.
   PubMed     Abstract available
   
   
   August 2025
2. THOMAS M
   Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer: Who Truly Benefits?
   AJR Am J Roentgenol. 2025 Aug 13. doi: 10.2214/AJR.25.33698.
   PubMed    
   
   
   
3. THOMAS M, Andrews-Tang D
   Beyond the AJR: Supplemental Breast Cancer Screening in Women with Dense Breasts in the United Kingdom-BRAID Study Shows Impressive Results, But at What Cost?
   AJR Am J Roentgenol. 2025 Aug 6. doi: 10.2214/AJR.25.33647.
   PubMed    
   
   
   July 2025
4. LIU B, Wu L, Liu C, Long X, et al
   Baseline and Early Treatment MRI Model for Predicting Complete Pathologic Response to Neoadjuvant Chemoimmunotherapy in Patients With Triple-Negative Breast Cancer.
   AJR Am J Roentgenol. 2025 Jul 30. doi: 10.2214/AJR.25.33178.
   PubMed     Abstract available
   
   
   June 2025
5. MCNULTY C, Chan T
   Beyond the AJR: Interval Cancers and the Case for Tailored Breast Cancer Screening.
   AJR Am J Roentgenol. 2025 Jun 18. doi: 10.2214/AJR.25.33368.
   PubMed    
   
   
   
6. CHEN SJ, Rahman A, Choi AY, Gahng JJ, et al
   Associations of Breast Cancer Method of Detection With Tumor Characteristics, Treatments, and Overall Survival: A Propensity-Score Matched Analysis.
   AJR Am J Roentgenol. 2025 Jun 18. doi: 10.2214/AJR.25.33245.
   PubMed     Abstract available
   
   
   
7. KARST I
   Standardizing Ultrafast MRI Time to Enhancement and Maximum Slope Wash-In Characteristics of BPE Versus Enhancing Lesions May Accelerate MRI's Adoption in Breast Cancer Screening.
   AJR Am J Roentgenol. 2025 Jun 11. doi: 10.2214/AJR.25.33217.
   PubMed    
   
   
   May 2025
8. TAKAHASHI T
   The Natural History of Screen-Detected Prostate and Breast Cancer.
   AJR Am J Roentgenol. 2025 May 28. doi: 10.2214/AJR.25.33170.
   PubMed    
   
   
   April 2025
9. NOORILY AR, Heller SL, Regen-Tuero HC, Li X, et al
   Novel Wash-In Characteristics of Background Parenchymal Enhancement on Ultrafast Dynamic Contrast-Enhanced Breast MRI.
   AJR Am J Roentgenol. 2025 Apr 23. doi: 10.2214/AJR.24.32624.
   PubMed     Abstract available
   
   
   
10. HOOLEY R, Honda M
    Beyond the AJR: The Challenge of Measuring the Impact of Variable Screening Recommendations on Breast Cancer Diagnosis and Treatment.
    AJR Am J Roentgenol. 2025 Apr 16. doi: 10.2214/AJR.25.32994.
    PubMed    
    
    
    
11. REGEN-TUERO HC, Gao Y, Li X, Noorily A, et al
    Time to Enhancement of Foci Relative to Background Parenchymal Enhancement on Ultrafast Breast MRI: A Single-Center Retrospective Study.
    AJR Am J Roentgenol. 2025 Apr 9. doi: 10.2214/AJR.24.32309.
    PubMed     Abstract available
    
    
    March 2025
12. NGUYEN DL, Langman EL, Johnson KS, Grimm LJ, et al
    Architectural Distortions Detected by DBT Alone With No Ultrasound Correlate and Nonmalignant Results on Core Needle Biopsy: Outcomes From an Imaging-Focused Management Strategy.
    AJR Am J Roentgenol. 2025 Mar 12. doi: 10.2214/AJR.25.32737.
    PubMed     Abstract available
    
    
    
13. CHALLAPALLI JV, Yoon JH, Ward RC
    Breast Cryoablation, From the AJR "How We Do It" Special Series.
    AJR Am J Roentgenol. 2025;224:e2431025.
    PubMed     Abstract available
    
    
    January 2025
14. SANDERS JW, Pavlicek W, Stefan W, Hanson J, et al
    Digital Mammography, Tomosynthesis, and Contrast-Enhanced Mammography: Intraindividual Comparison of Mean Glandular Dose for Screening Examinations.
    AJR Am J Roentgenol. 2025 Jan 15. doi: 10.2214/AJR.24.32150.
    PubMed     Abstract available
    
    
    December 2024
15. CHO SM, Cha JH, Kim HH, Shin HJ, et al
    Nonmass Lesions on Breast Ultrasound: Interreader Agreement and Associations With Malignancy.
    AJR Am J Roentgenol. 2024 Dec 18. doi: 10.2214/AJR.24.32278.
    PubMed     Abstract available
    
    
    
16. KWOK Y
    Editorial Comment: Disparate Access to Breast Cancer Screening Is a Multifaceted Problem.
    AJR Am J Roentgenol. 2024 Dec 11. doi: 10.2214/AJR.24.32468.
    PubMed    
    
    
    November 2024
17. FAZELI S, Narayan A, Mango VL, Wahad R, et al
    Access to Breast Cancer Screening: Disparities and Determinants-AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2024 Nov 27. doi: 10.2214/AJR.24.32151.
    PubMed     Abstract available
    
    
    
18. OLUYEMI E
    Editorial Comment: An Alternate Method for Primary Breast Cancer Screening in Low-Resource Settings.
    AJR Am J Roentgenol. 2024 Nov 6. doi: 10.2214/AJR.24.32256.
    PubMed    
    
    
    
19. CHIKARMANE SA
    Editorial Comment: The Role of Automated Breast Ultrasound and Teleradiology for Breast Cancer Screening-An International Perspective.
    AJR Am J Roentgenol. 2024 Nov 6. doi: 10.2214/AJR.24.32287.
    PubMed    
    
    
    October 2024
20. DANG X, Gao Y, Ju Y, Yuan X, et al
    Automated Breast Ultrasound With Remote Reading for Primary Breast Cancer Screening: A Prospective Study Involving 46 Community Health Centers in China.
    AJR Am J Roentgenol. 2024 Oct 23. doi: 10.2214/AJR.24.31830.
    PubMed     Abstract available
    
    
    
21. CHEN Y, Chen S, Tang W, Konge Q, et al
    Multiparametric MRI Radiomics With Machine Learning for Differentiating HER2-Zero, -Low, and -Positive Breast Cancer: Model Development, Testing, and Interpretability Analysis.
    AJR Am J Roentgenol. 2024 Oct 16. doi: 10.2214/AJR.24.31717.
    PubMed     Abstract available
    
    
    
22. CLARK AI
    Neglected Breast Cancers in an Era of Early Detection: Focus on Female Caregivers.
    AJR Am J Roentgenol. 2024;223:e2431594.
    PubMed     Abstract available
    
    
    September 2024
23. CHIKARMANE SA, Slanetz PJ
    Beyond the AJR: Contrast-Enhanced Mammography Supplemental Screening in Individuals at Elevated Risk for Breast Cancer.
    AJR Am J Roentgenol. 2024 Sep 25. doi: 10.2214/AJR.24.32084.
    PubMed    
    
    
    
24. OUEIDAT K, Ward RC
    Reply to: "Optimizing Cryoablation for Breast Cancer: Proposals for Extended Follow-Up and Methodological Enhancements".
    AJR Am J Roentgenol. 2024 Sep 11. doi: 10.2214/AJR.24.32013.
    PubMed    
    
    
    
25. GUO X, Li P, Wang Y
    Optimizing Cryoablation for Breast Cancer: Proposals for Extended Follow-Up and Methodological Enhancements.
    AJR Am J Roentgenol. 2024 Sep 11. doi: 10.2214/AJR.24.31933.
    PubMed    
    
    
    August 2024
26. WOODARD S, Kleiman K
    Virtual Reality Simulation-Based Training in Image-Guided Breast Intervention in Low- and Middle-Income Countries.
    AJR Am J Roentgenol. 2024;223:e2431236.
    PubMed     Abstract available
    
    
    July 2024
27. OZCAN BB, Xi Y, Dogan BE, Porembka JH, et al
    Cost-Effectiveness of an Ultrasound-First Strategy in the Diagnostic Evaluation of Noncalcified Lesions Recalled From Screening Digital Breast Tomosynthesis.
    AJR Am J Roentgenol. 2024 Jul 31. doi: 10.2214/AJR.24.31422.
    PubMed     Abstract available
    
    
    
28. DONATO F JR
    Editorial Comment: Breast Cryoablation-A Minimally Invasive Alternative in Breast Cancer Treatment.
    AJR Am J Roentgenol. 2024 Jul 24. doi: 10.2214/AJR.24.31789.
    PubMed    
    
    
    
29. OUEIDAT K, Baird GL, Barclay-White B, Kozlowski K, et al
    Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study.
    AJR Am J Roentgenol. 2024 Jul 10. doi: 10.2214/AJR.24.31392.
    PubMed     Abstract available
    
    
    June 2024
30. THOMAS M
    Editorial Comment: Abbreviated Breast MRI on Repeat-Is This a New Era for Breast Cancer Screening?
    AJR Am J Roentgenol. 2024 Jun 5. doi: 10.2214/AJR.24.31513.
    PubMed    
    
    
    
31. MARGOLIES LR
    Editorial Comment: What Does Advertising Abbreviated Breast MRI to Patients With Dense Breasts Accomplish?
    AJR Am J Roentgenol. 2024 Jun 5. doi: 10.2214/AJR.24.31520.
    PubMed    
    
    
    
32. GARRETT HV, Bennett DL
    Axillary Seed Localization With Digital Breast Tomosynthesis Guidance: A Novel Technique Using Anterior Approach and Modified Stereotactic Guidance.
    AJR Am J Roentgenol. 2024;222:e2430994.
    PubMed    
    
    
    
33. CROWLEY C, Bahl M
    Radial Scars on Screening Digital Breast Tomosynthesis: Upstaging Rates and Management Strategies.
    AJR Am J Roentgenol. 2024;222:e2430845.
    PubMed     Abstract available
    
    
    May 2024
34. MORRIS MF, Welk LA, Harrison M, Summers D, et al
    Sequential Contrast Media Injections for Multisite and Same-Day Contrast-Enhanced Mammography-Guided Biopsy.
    AJR Am J Roentgenol. 2024 May 29. doi: 10.2214/AJR.24.31343.
    PubMed    
    
    
    
35. EDMONDS CE, Weinstein SP, McDonald ES, Bagheri S, et al
    Abbreviated Breast MRI for Supplemental Screening in Patients With Dense Breasts: Comparison of Baseline Versus Subsequent-Round Examinations.
    AJR Am J Roentgenol. 2024 May 22. doi: 10.2214/AJR.24.31098.
    PubMed     Abstract available
    
    
    
36. HAVER HL, Yi PH, Jeudy J, Bahl M, et al
    Use of ChatGPT to Assign BI-RADS Assessment Categories to Breast Imaging Reports.
    AJR Am J Roentgenol. 2024 May 8. doi: 10.2214/AJR.24.31093.
    PubMed    
    
    
    
37. WONG JB
    New USPSTF Breast Cancer Screening Recommendations: A Talk With Task Force Vice Chair Dr John Wong.
    AJR Am J Roentgenol. 2024 May 7. doi: 10.2214/AJR.24.31404.
    PubMed     Abstract available
    
    
    
38. YEH ED
    Editorial Comment: Breast Cryoablation-A Promising Technology to Nonsurgically Treat Small Low-Risk Breast Cancer.
    AJR Am J Roentgenol. 2024 May 1. doi: 10.2214/AJR.24.31346.
    PubMed    
    
    
    March 2024
39. GASTOUNIOTI A, Kontos D
    Artificial Intelligence in Breast Imaging Daily Clinical Practice: Point-Reshaping Breast Cancer Screening.
    AJR Am J Roentgenol. 2024 Mar 27. doi: 10.2214/AJR.24.31174.
    PubMed    
    
    
    
40. MULLEN LA, Ambinder EB
    Artificial Intelligence in Breast Imaging Daily Clinical Practice: Counterpoint-Proceed With Caution.
    AJR Am J Roentgenol. 2024 Mar 27. doi: 10.2214/AJR.24.30962.
    PubMed    
    
    
    February 2024
41. HUANG ML, Lane DL, Santiago L
    MRI-Guided Breast Cryoablation With the Patient in Prone Position.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30754.
    PubMed    
    
    
    
42. BAHL M, Chang JM, Mullen LA, Berg WA, et al
    Artificial Intelligence for Breast Ultrasound: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30645.
    PubMed     Abstract available
    
    
    January 2024
43. MARGOLIES LR
    Beyond the AJR: Breast MRI Finds More Breast Cancers Than Mammography.
    AJR Am J Roentgenol. 2024 Jan 3. doi: 10.2214/AJR.23.30782.
    PubMed    
    
    
    December 2023
44. JIRARAYAPONG J, Portnow LH, Chikarmane SA, Lan Z, et al
    High Peritumoral and Intratumoral T2 Signal Intensity in HER2+ Breast Cancers on Preneoadjuvant Breast MRI: Assessment of Associations With Histopathologic Characteristics.
    AJR Am J Roentgenol. 2023 Dec 20. doi: 10.2214/AJR.23.30280.
    PubMed     Abstract available
    
    
    
45. COVINGTON MF, O'Brien SR, Lawhn-Heath C, Pantel AR, et al
    Fluorine-18-Labeled Fluoroestradiol PET/CT: Current Status, Gaps in Knowledge, and Controversies-AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023 Dec 20. doi: 10.2214/AJR.23.30330.
    PubMed     Abstract available
    
    
    
46. NGUYEN DL, Greenwood HI, Rahbar H, Grimm LJ, et al
    Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs.
    AJR Am J Roentgenol. 2023 Dec 13. doi: 10.2214/AJR.23.30503.
    PubMed     Abstract available
    
    
    November 2023
47. HUPPE AI, Loving VA, Slanetz PJ, Destounis S, et al
    Optimizing the Patient Experience in Breast Imaging Facilities: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023 Nov 15. doi: 10.2214/AJR.23.29995.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.